Compugen (CGEN) Non-Current Deferred Tax Liability (2010 - 2015)
Compugen (CGEN) reported Non-Current Deferred Tax Liability of $105000.0 for Q3 2015, down 80.04% on a YoY basis from $526000.0 in Q3 2014, and down 50.0% sequentially from $210000.0 in Q2 2015.
Compugen (CGEN) Non-Current Deferred Tax Liability (2010 - 2015) Analysis & Trends
Compugen (CGEN) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $105000.0 in Q3 2015.
- For the quarter ending Q3 2015, Non-Current Deferred Tax Liability fell 80.04% year-over-year to $105000.0; the trailing twelve-month figure through Sep 2015 stood at $105000.0 (down 80.04% YoY), and the FY2014 full-year result was $421000.0, down 96.81% from the prior year.
- Non-Current Deferred Tax Liability fell to $105000.0 in Q3 2015, from $210000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $14.2 million in Q1 2014 to a low of $105000.0 in Q3 2015.
- A 5-year average of $5.8 million and a median of $4.8 million in 2012 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability soared 142.68% in 2013 and slumped 98.39% in 2015, its largest moves.
- Tracing CGEN's Non-Current Deferred Tax Liability over 5 years: stood at $6.1 million in 2011, then gained by 28.0% to $7.9 million in 2012, then soared by 67.54% to $13.2 million in 2013, then plunged by 96.81% to $421000.0 in 2014, then tumbled by 75.06% to $105000.0 in 2015.
- Business Quant data shows CGEN's Non-Current Deferred Tax Liability at $105000.0 in Q3 2015, $210000.0 in Q2 2015, and $316000.0 in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 105,000.00 |
| Sep 30, 2015 | 105,000.00 |
| Jun 30, 2015 | 210,000.00 |
| Jun 30, 2015 | 210,000.00 |
| Mar 31, 2015 | 316,000.00 |
| Mar 31, 2015 | 316,000.00 |
| Dec 31, 2014 | 421,000.00 |
| Dec 31, 2014 | 421,000.00 |
| Sep 30, 2014 | 526,000.00 |
| Sep 30, 2014 | 526,000.00 |
| Jun 30, 2014 | 13.07 Mn |
| Jun 30, 2014 | 13.07 Mn |
| Mar 31, 2014 | 14.15 Mn |
| Mar 31, 2014 | 14.15 Mn |
| Dec 31, 2013 | 13.19 Mn |
| Dec 31, 2013 | 13.19 Mn |
| Sep 30, 2013 | 14.10 Mn |
| Sep 30, 2013 | 14.10 Mn |
| Dec 31, 2012 | 7.87 Mn |
| Dec 31, 2012 | 7.87 Mn |